Screener Summaries Updates Institutions Sign In More Updates › Financing › RGNT Financing · Jun 15, 2026
Regentis Biomaterials Ltd. filed a request with the SEC on June 15, 2026, to withdraw its Registration Statement No.… RGNT Regentis Biomaterials Ltd.
Regentis Biomaterials Ltd. filed a request with the SEC on June 15, 2026, to withdraw its Registration Statement No. 333-295510 on Form F-1. The company decided not to proceed with the public offering associated with that registration statement. Regentis Biomaterials Ltd. is a biotechnology company focused on biomaterials.
More from Regentis Biomaterials Ltd. Regentis Biomaterials reported a net loss of $2.6 million, or $0.44 per share, for the six months ended June 30, 2026… Sep 11, 2026 Regentis Biomaterials Ltd. announced that the Japan Patent Office has issued a Notice of Allowance for its proprietary… Jul 20, 2026 On July 15, 2026, Regentis Biomaterials Ltd. announced it received European regulatory approval for a new GelrinC… Jul 15, 2026 On July 9, 2026, Regentis Biomaterials Ltd. announced that shareholders approved all fourteen proposals presented at… Jul 9, 2026 Regentis Biomaterials Ltd. adjourned its Annual General Meeting of Shareholders, originally scheduled for July 2… Jul 2, 2026 All content on this site is for informational purposes only and does not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. Always consult a qualified financial advisor before making investment decisions.
Financial data is obtained from public filings and third-party providers and is provided “as-is” without any guarantee of accuracy, completeness, or timeliness.
© 2026 go-intrinsic.com. All rights reserved.
